1. |
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005; 55(2)∶74.
|
2. |
Tang ZY, Ye SL, Liu YK, et al. A decade’s studies on metastasis of hepatocellular carcinoma [J]. J Cancer Res Clin Oncol, 2004; 130(4)∶187.
|
3. |
Mitsunobu M, Toyosaka A, Oriyama T, et al. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel [J]. Clin Exp Metastasis, 1996; 14(6)∶520.
|
4. |
Liotta L, Petricoin E. Molecular profiling of human cancer [J]. Nat Rev Genet, 2000; 1(1)∶48.
|
5. |
Elston CW, Sloane JP, Amendoeira I, et al. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology [J]. Eur J Cancer, 2000; 36(14)∶1769.
|
6. |
TungPing Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [J]. Ann Surg, 2000; 232(1)∶10.
|
7. |
Kobayashi T, Kubota K, Takayama T, et al. Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy [J]. Am J Surg, 2001; 181(3)∶284.
|
8. |
Ijichi M, Takayama T, Matsumura M, et al. alphaFetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study [J]. Hepatology, 2002; 35(4)∶853.
|
9. |
Huang GT, Lee HS, Chen CH, et al. Correlation of Ecadherin expression and recurrence of hepatocellular carcinoma [J]. Hepatogastroenterology, 1999; 46(27)∶1923.
|
10. |
Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray [J]. Science, 1995; 270(5235)∶467.
|
11. |
DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer [J]. Nat Genet, 1996; 14(4)∶457.
|
12. |
Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring [J]. Science, 1999; 286(5439)∶531.
|
13. |
Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large Bcell lymphoma identified by gene expression profiling [J]. Nature, 2000; 403(6769)∶503.
|
14. |
Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours [J]. Nature, 2000; 406(6797)∶747.
|
15. |
van’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer [J]. Nature, 2002; 415(6871)∶530.
|
16. |
Weigelt B, Glas AM, Wessels LF, et al. Gene expression profiles of primary breast tumors maintained in distant metastases [J]. Proc Natl Acad Sci USA, 2003; 100(26)∶15901.
|
17. |
Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumors [J]. Nat Genet, 2003; 33(1)∶49.
|
18. |
Onken MD, Ehlers JP, Worley LA, et al. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas [J]. Cancer Res, 2006; 66(9)∶4602.
|
19. |
Carrasco DR, Tonon G, Huang Y, et al. Highresolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients [J]. Cancer Cell, 2006; 9(4)∶313.
|
20. |
Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B viruspositive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning [J]. Nat Med, 2003; 9(4)∶416.
|
21. |
Iizuka N, Oka M, YamadaOkabe H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection [J]. Lancet, 2003; 361(9361)∶923.
|